Equity Analyst, LightStream Research

Shifara Samsudeen, ACMA, CGMA

A chartered management accountant with more than 10 years of rich experience in investment research and financial analysis. Worked as an equity analyst for one of the world's largest asset managers with USD2.5trn in AUM covering numerous sectors including chemicals, retail, tech, autos, telco, real-estate and banks, globally. Experienced in fundamental equity research, industry research, commodity studies, forensic accounting, and due diligence reviews.

Equity Analyst

Tencent: Weakening Online Games; Cautions Investors that More Regulatory Changes Are to Come

Novotech Health IPO: Structural Tailwinds in the APAC Biotech CRO Market Offers LT Growth

Broncus Holdings IPO: Say No to Lung Diseases

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

Equity Capital Markets

EDDA Healthcare and Technology / Equity Capital Markets

<a href="https://www.smartkarma.com/entities/edda-healthcare-and-technology-holding-limited" target="_blank" data-smartkarma-citation="entities:33805:1" rel="noopener">EDDA Healthcare and Technology (EDD HK)</a> is a provider of intelligent solutions (involving surgical robots and precision surgery planning) to perform precision surgery. The company’s core products are its surgical robot series: IQQA-Guide and a precision surgery planning software: IQQA-3D.EDDA Healthcare has filed for an IPO in the Hong Kong Stock Exchange and according to Bloomberg, the company plans to raise around US$300m through the IPO. The company is backed by SoftBank Group.EDDA Healthcare has over 15 years of experience in providing precision surgery solutions. The precision surgery planning market shows strong growth prospects which would allow the company to continue generating strong revenues. Moreover, the company’s latest introduction of a surgical robot is likely to become a stronger revenue driver in future given that China’s surgical robot industry is still in a nascent stage and is rapidly expanding.

EDDA Healthcare and Technology (EDD HK) is a provider of intelligent solutions (involving surgical robots and precision surgery planning) to perform precision surgery. The company’s core products are its surgical robot series: IQQA-Guide and a precision surgery planning software: IQQA-3D.EDDA Healthcare has filed for an IPO in the Hong Kong Stock Exchange and according to Bloomberg, the company plans to raise around US$300m through the IPO. The company is backed by SoftBank Group.EDDA Healthcare has over 15 years of experience in providing precision surgery solutions. The precision surgery planning market shows strong growth prospects which would allow the company to continue generating strong revenues. Moreover, the company’s latest introduction of a surgical robot is likely to become a stronger revenue driver in future given that China’s surgical robot industry is still in a nascent stage and is rapidly expanding.

EDDA Healthcare IPO: Surgical Robots Show Strong Growth Prospects